GLUCERNA POWDER

MOST CLINICALLY PROVEN DIABETES NUTRITION BRAND IN THE WORLD

  • Advanced, complex, slowly digested, carbohydrate blend with low GI ingredients^ (including dual fiber blend) to help manage blood sugar
  • Helps promote the secretion of GLP-1 to improve insulin secretion1, helps lower postprandial glucose response2,3 and HbA1c4
  • Contains 4x myo-inositol† to help improve insulin sensitivity#,5-7
  • Complete, balanced nutrition with 18 vitamins & minerals and low sugar, low-GI* formulation
  • Nutrition profile meets recommendations of ADA***

 

IMPORTED FROM SINGAPORE

Ingredients

Maltodextrin, VEGETABLE OILS (high oleic sunflower oil, soy oil), calcium caseinate, sucromalt, isolated soy protein, maltitol, milk protein concentrate, fructose, MINERALS (potassium chloride, magnesium phosphate dibasic, potassium phosphate dibasic, calcium carbonate, sodium chloride, sodium sulfate, magnesium sulfate, potassium citrate, sodium citrate, zinc sulfate, ferrous sulfate, manganese sulfate, copper sulfate, chromium picolinate, chromium chloride, potassium iodide, sodium molybdate, sodium selenate), oligofructose, isomaltulose, myo-inositol, oat fiber, flavoring, stabilizer (carboxymethyl cellulose), choline chloride, emulsifier (lecithin), VITAMINS (ascorbic acid, antioxidant (ascorbyl palmitate), antioxidant (mixed tocopherols), Vitamin E, niacinamide, calcium pantothenate, thiamin hydrochloride, pyridoxine hydrochloride, riboflavin, Vitamin A palmitate, folic acid, phylloquinone, biotin, Vitamin D3, cyanocobalamin), stabilizer (xanthan gum), taurine, L-carnitine. Fibersol-2 is used as part of maltodextrin.

Contains milk and soy ingredients.

Nutrition Information

Nutrition Information
UnitPer 100gPer 100ml
 
UnitPer 100gPer 100ml
Energykcal43796Vitamin B1mg0.710.16
Proteing19.504.29Vitamin B2mg0.750.17
Fatg16.703.67Niacin equivalentsmg NE7.361.62
  Saturated fatty acidsg2.100.46Vitamin B6mg0.960.21
  Monounsaturated fatty acidsg7.771.71Folic acidµg12427
      Polyunsaturated fatty acidsg3.780.83Vitamin B12µg1.270.28
          n-3 fatty acidsg0.300.07Biotinµg14.43.2
              α-linolenic acidg0.300.07Pantothenic acidmg2.960.65
       n-6 fatty acidsg3.480.77MINERALS
              Linoleic acidg3.480.77Sodiummg44097
  Trans fatg0.250Potassiummg576127
Cholesterolmg80Chloridemg481106
Total carbohydrateg57.6012.67Calciummg34375
      Carbohydrateg50.1111.02Phosphorusmg25957
          Sugarsg10.772.37Magnesiummg91.220.1
      Polyolsg6.251.38Ironmg3.230.71
         Maltitolg6.251.38Zincmg4.601.01
      Fiberg7.491.65Copperµg25656
          Soluble fiberg6.531.44Manganesemg1.200.26
              Oligofructose (FOS)g2.050.45Seleniumµg24.05.3
          Insoluble fiberg0.960.21Chromiumµg60.813.4
Carnitinemg33.07.3Molybdenumµg40.08.8
Taurinemg38.28.4Iodineµg58.412.8
Cholinemg191.042.0OTHER CHARACTERISTICS
Inositolmg1536.0337.9Osmolality mOsm/kgH2O455 
VITAMINSkcal/N (Non-protein kcal/N) ratio140:1 (115:1)
Vitamin Aµg RE31870Renal Solute Load mOsm/L365 
Viatmin D3µg12.502.75Gluten freeYes
Vitamin Emg α-TE8.11.8Suitable for individuals with lactose sensitivity/intolerance
Vitamin K1µg30.46.7    
Vitamin Cmg32.87.2    

 

RELATED PRODUCTS

RELATED CONTENT

Examining guidelines and new evidence in oncology nutrition

Examining guidelines and new evidence in oncology nutrition

Main Image


resource

Tagname
Article
title
Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/Examining-guidelines-and-new-evidence-in-oncology-nutrition-a-position-paper-on-gaps-and-opportunities-in-multimodal-approaches-to-improve-pati
Abstract

Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes. 

Publish Date:
Oct 2021

The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)

Main Image

resource

Tagname
ARTICLE
title
The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/hmb-article
Abstract

The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.

Publish Date:

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

Main Image

resource

Tagname
Article
title
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/The-Underappreciated-Role-of-Low-Muscle-Mass-in-the-Management-of-Malnutrition
Abstract

This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.

Publish Date:
Jan 2019

Footnotes:

△ Based on published clinical studies only. Literature search was conducted in Dialog databases and Dimensions full-text searching database in August 2022.

*** American Diabetes Association. Diabetes Care 2023;46(Suppl 1):S68-S96. Meets American Diabetes Association's recommendations for dietary fiber, sodium, monounsaturated fatty acids, polyunsaturated fatty acids, trans fatty acids and saturated fatty acids.

▲ This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease. 此產品沒有根據<藥劑業及毒藥條例>或<中醫藥條例>註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。

^ Low glycemic index ingredients include: (for Powder) fibersol-2, sucromalt, maltitol, fructose, isomaltulose, FOS and oat fiber.

† New Glucerna contains 337.9mg/100ml (Powder), 292mg/100ml (Bottle); Previous Glucerna contained 84mg/100ml (Powder), 0mg/100ml (Bottle); Compared with previous Glucerna triple care formulation.

#Inositol helps supports insulin sensitivity by promoting GLUT4 translocation thus increasing glucose entry into the cell.

*Sugar 2.4g/100ml, GI=31 (for Powder)

References:

  1. Devitt AA et al., J Diabetes Res Clin Mtab. 2012;1:20
  2. Mottalib et al., Nutrients. 2016 Jul 11;8(7):443
  3. Devitt AA et al., Advances in Bioscience and Biotechnology, 2013, 4, 1-10
  4. Chee SS et al., BMJ Open Diabetes Res Care. 2017;5(1):e000384.
  5. Bevilacqua A, et al. Int J Endocrinol. 2018:1968450
  6. Dang NT, et al. Biosci Biotechnol Biochem. 2010;74(5):1062-1067
  7. Yamashita Y, et al. J agric Food Chem. 2013;61(20):4850-4854

 

HKG.2025.58198.AND.1

Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
Loading...

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.

You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.

UK-N/A-2400058 (V8) | October 2024
bookmarkbookmarkedbookmark-hover
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click this link.